IVAN ROSAS to Immunoglobulins, Intravenous
This is a "connection" page, showing publications IVAN ROSAS has written about Immunoglobulins, Intravenous.
Connection Strength
0.052
-
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis. BMC Pulm Med. 2024 Mar 20; 24(1):143.
Score: 0.052